* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Thymic Protein A - Complementary Prescriptions
Survey
Document related concepts
Immune system wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Adaptive immune system wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Drosophila melanogaster wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
DNA vaccination wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Innate immune system wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Molecular mimicry wikipedia , lookup
Immunosuppressive drug wikipedia , lookup
Transcript
Thymic Protein A c DESCRIPTION PRECAUTIONS Researchers have discovered a sobering fact: abnormal cells, such as cancer or tumor cells, are present in everyone's body—even those individuals who exhibit no signs of disease. Despite this fact, only one in 25 people are diagnosed with cancer. Scientists have begun to understand why the remaining 24 individuals do not succumb to carcinogenesis. These healthy individuals have developed a strong immune response known as cell-mediated immunity, the body's defense against foreign invaders in the body. Research has indicated that individuals with the longest life spans have enhanced cellmediated immunity. Thymic Protein A is contraindicated when large doses of steroidal hormones are administered, such as during prostate cancer treatments. Excessive steroid levels interfere with the protein's ability to adhere to lymphocytes. However, Thymic Protein A is effective in postmenopausal women undergoing hormone replacement therapy. Cell-Mediated Immunity The agents responsible for cell-mediated immunity are white blood cells called T-lymphocytes (T-cells). There are two types of T-cells: T-4 lymphocytes and T-8 lymphocytes. The T-4 cells locate invaders such as tumor cells, viruses, bacteria and parasites, then direct the T-8 cells to the location, where the abnormality is destroyed. T-4 cells cannot do their job properly, however, unless proteins from the thymus gland teach them how to perform effectively. Despite this integral immune function, however, the thymus begins to shrink after puberty. In most adults over 40, the thymus has shriveled to near nothing, leaving the body vulnerable to degenerative diseases. The active ingredient in Proboost Thymic Protein A is the precise thymus protein known to program the T-4 lymphocytes, thereby enhancing cell-mediated immunity. Immunologist Terry Beardsley, Ph.D., who discovered Thymic Protein A 23 years ago, is the first scientist to produce the protein in an intact manner in the laboratory through the use of cultured human thymus epithelial cells. Thymic Protein A contains all 500 amino acids that comprise the thymic protein molecules already in existence in the body. Other thymus products contain only fragments (Thymopoetin contains only 5 amino acids, Thymosin only 13). Because Thymic Protein A is unfragmented it fits into the T-4 cell receptor site, triggering enhanced activity of the body's most powerful immune defense. Immune Stimulant Research in both animals and humans has demonstrated that Thymic Protein A has an astounding ability to enhance the immune system. Animals lacking a thymus gland, when exposed to a non-sterile environment, normally contract a variety of infections. Conversely, mice receiving human thymus epithelial cells (from which Thymic Protein A is derived), develop no infections even when living outside a sterile environment. In another study, Thymic Protein A enhanced immune response and suppressed the disease of 22 cats infected with the Feline Immunodeficiency Virus (FIV), the equivalent of AIDS. In addition, SmithKline Beecham's animal health research division discovered that a minute amount of Thymic Protein A added to the rabies vaccination of dogs doubles the potency and immune protection of the vaccine. In humans, Thymic Protein A has demonstrated impressive results against a host of conditions. In a recent pilot study, six individuals with Epstein-Barr virus (EBV) and chronically elevated EBV antibodies were treated with 12 micrograms of Thymic Protein A daily for 60 days. The treatment produced a 50% or greater reduction in the level of Early Antigen Epstein-Barr viral loads in the majority of individuals tested. Subjects also reported increased energy. These results suggest that Thymic Protein A may be effective in the treatment of mononucleosis and chronic fatigue syndrome, two conditions associated with EBV. The U.S. National Institute of Health (NIH) Division of AIDS has conducted its own trials. In these studies, Thymic Protein A has suppressed HIV and live HIV-infected blood cells. The researchers concluded that Thymic Protein A is an immune stimulant. RECOMMENDED DOSAGE One to three packets per day, taken sublingually. Individuals seeking to improve immune function can take one packet daily. Those with severe health problems may require three packets per day until their immune system is restored, at which time the dosage can be reduced. Individuals with HIV or hepatitis B or C should take three doses per day until blood tests have been normal for three to six months, then reduce to one dose per day. Because the product is purified, there have been no allergic reactions reported to Thymic Protein A, as is sometimes the case with whole thymus extracts. PRODUCT CODE #9122 30 pack (4 mcg) FORMULA Supplement Facts Serving Size: 1 Packet Amount Per Serving Thymic Protein A % Daily Value 4 mcg. * Other Ingredients: Maltodextrin *Daily Value not established REFERENCES 1. Hays EF, Beardsley TR. Immunologic effects of human thymic stromal grafts and cell lines. Clin Immunol Immunopathol. 1984; 33(3):381-90. 2. Beardsley TR, Pierschbacher M, Wetzel GD, Hays EF. Induction of T-cell maturation by a cloned line of thymic epithelium (TEPI). Proc Natl Acad Sci USA. 1983; 80(19):6005-9. 3. Lapcevic J. A new biologically active thymic protein to stimulate cell-mediated immunity. Townsend Newsletter for Doctors and Patients. 1997; Feb-Mar:70-2. 4. Hale P. The FIV connection. Searchlight. 1996; Summer:21-3. 5. Riordan N, et al. Pilot study of the effects of thymus protein on elevated Epstein-Barr virus titers. Townsend Newsletter for Doctors and Patients. 1998; Feb-Mar:78-9. Additional Benefits Abundant anecdotal evidence also exists. There have been numerous reports of chemotherapy patients who have maintained their total white blood count at acceptable levels while treated with Thymic Protein A. Furthermore, physicians have used this nutrient to successfully treat patients suffering from colds, flu, herpes shingles, sinusitis and hepatitis. Researchers are currently conducting trials to investigate its role in cancer therapy. Thymic Protein A is an exciting new anti-aging development. In the words of Dr. Julian Whitaker, Thymic Protein A is "..likely the most powerful natural stimulant of the immune system ever discovered." CP ver. 082203 Information contained in this Product Technical Sheet is for educational purposes only and is not intended to provide personal medical advice. Such advice should be obtained from a medical professional. Reproduction of any part of this work is prohibited. ® 2003 Complementary Prescriptions™, a division of Vitamin Research Products, Inc.